Cargando…

Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations

BACKGROUND & OBJECTIVES: Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder and is caused mainly by deletion, duplication and point mutations in the DMD gene. Diagnosis of DMD has been a challenge as the mutations in the DMD gene are heterogeneous and require more than one diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Aravind, Sankaramoorthy, Ashley, Berty, Mannan, Ashraf, Ganapathy, Aparna, Ramesh, Keerthi, Ramachandran, Aparna, Nongthomba, Upendra, Shastry, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886143/
https://www.ncbi.nlm.nih.gov/pubmed/31719299
http://dx.doi.org/10.4103/ijmr.IJMR_290_18
_version_ 1783474825841344512
author Aravind, Sankaramoorthy
Ashley, Berty
Mannan, Ashraf
Ganapathy, Aparna
Ramesh, Keerthi
Ramachandran, Aparna
Nongthomba, Upendra
Shastry, Arun
author_facet Aravind, Sankaramoorthy
Ashley, Berty
Mannan, Ashraf
Ganapathy, Aparna
Ramesh, Keerthi
Ramachandran, Aparna
Nongthomba, Upendra
Shastry, Arun
author_sort Aravind, Sankaramoorthy
collection PubMed
description BACKGROUND & OBJECTIVES: Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder and is caused mainly by deletion, duplication and point mutations in the DMD gene. Diagnosis of DMD has been a challenge as the mutations in the DMD gene are heterogeneous and require more than one diagnostic strategy for the validation of the mutation. This study was planned to evaluate the targeted next-generation sequencing (NGS) as a single platform to detect all types of mutations in the DMD gene, thereby reducing the time and costs compared to conventional sequential testing and also provide precise genetic information for emerging gene therapies. METHODS: The study included 20 unrelated families and 22 patients from an Indian population who were screened for DMD based on phenotypes such as scoliosis, toe walking and loss of ambulation. Peripheral blood DNA was isolated and subjected to multiplex ligation-dependent probe amplification (MLPA) and targeted NGS of the DMD gene to identify the nature of the mutation. RESULTS: In the study patients, 77 per cent of large deletion mutations and 23 per cent single-nucleotide variations (SNVs) were identified. Novel mutations were also identified along with reported deletions, point mutations and partial deletions within the exon of the DMD gene. INTERPRETATION & CONCLUSIONS: Our findings showed the importance of NGS in the routine diagnostic practice in the identification of DMD mutations over sequential testing. It may be used as a single-point diagnostic strategy irrespective of the mutation type, thereby reducing the turnaround time and cost for multiple diagnostic tests such as MLPA and Sanger sequencing. Though MLPA is a sensitive technique and is the first line of a diagnostic test, the targeted NGS of the DMD gene may have an advantage of having a single diagnostic test. A study on a larger number of patients is needed to highlight NGS as a single, comprehensive platform for the diagnosis of DMD.
format Online
Article
Text
id pubmed-6886143
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68861432019-12-09 Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations Aravind, Sankaramoorthy Ashley, Berty Mannan, Ashraf Ganapathy, Aparna Ramesh, Keerthi Ramachandran, Aparna Nongthomba, Upendra Shastry, Arun Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder and is caused mainly by deletion, duplication and point mutations in the DMD gene. Diagnosis of DMD has been a challenge as the mutations in the DMD gene are heterogeneous and require more than one diagnostic strategy for the validation of the mutation. This study was planned to evaluate the targeted next-generation sequencing (NGS) as a single platform to detect all types of mutations in the DMD gene, thereby reducing the time and costs compared to conventional sequential testing and also provide precise genetic information for emerging gene therapies. METHODS: The study included 20 unrelated families and 22 patients from an Indian population who were screened for DMD based on phenotypes such as scoliosis, toe walking and loss of ambulation. Peripheral blood DNA was isolated and subjected to multiplex ligation-dependent probe amplification (MLPA) and targeted NGS of the DMD gene to identify the nature of the mutation. RESULTS: In the study patients, 77 per cent of large deletion mutations and 23 per cent single-nucleotide variations (SNVs) were identified. Novel mutations were also identified along with reported deletions, point mutations and partial deletions within the exon of the DMD gene. INTERPRETATION & CONCLUSIONS: Our findings showed the importance of NGS in the routine diagnostic practice in the identification of DMD mutations over sequential testing. It may be used as a single-point diagnostic strategy irrespective of the mutation type, thereby reducing the turnaround time and cost for multiple diagnostic tests such as MLPA and Sanger sequencing. Though MLPA is a sensitive technique and is the first line of a diagnostic test, the targeted NGS of the DMD gene may have an advantage of having a single diagnostic test. A study on a larger number of patients is needed to highlight NGS as a single, comprehensive platform for the diagnosis of DMD. Wolters Kluwer - Medknow 2019-09 /pmc/articles/PMC6886143/ /pubmed/31719299 http://dx.doi.org/10.4103/ijmr.IJMR_290_18 Text en Copyright: © 2019 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Aravind, Sankaramoorthy
Ashley, Berty
Mannan, Ashraf
Ganapathy, Aparna
Ramesh, Keerthi
Ramachandran, Aparna
Nongthomba, Upendra
Shastry, Arun
Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations
title Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations
title_full Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations
title_fullStr Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations
title_full_unstemmed Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations
title_short Targeted sequencing of the DMD locus: A comprehensive diagnostic tool for all mutations
title_sort targeted sequencing of the dmd locus: a comprehensive diagnostic tool for all mutations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886143/
https://www.ncbi.nlm.nih.gov/pubmed/31719299
http://dx.doi.org/10.4103/ijmr.IJMR_290_18
work_keys_str_mv AT aravindsankaramoorthy targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT ashleyberty targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT mannanashraf targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT ganapathyaparna targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT rameshkeerthi targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT ramachandranaparna targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT nongthombaupendra targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations
AT shastryarun targetedsequencingofthedmdlocusacomprehensivediagnostictoolforallmutations